Fluorouracil (Carac)
14843
relevant articles (1633 outcomes,
3906 trials/studies)
found for this Drug
Description:
A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
Also Known As:
Carac; 5 Fluorouracil; 5-Fluorouracil; Adrucil; Efudex; Fluoroplex; 5-FU; 5-FU Lederle; 5-FU medac; 5-Fluorouracil-biosyn; 5-HU Hexal; 5FU; Allergan Brand of Fluorouracil; CSP Brand of Fluorouracil; Dakota Brand of Fluorouracil; Dermatech Brand of Fluorouracil; Dermik Brand of Fluorouracil; Efudix; Ferrer Brand of Fluorouracil; Fluoro-Uracile ICN; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil-GRY; Fluorouracile Dakota; Fluorouracilo Ferrer Far; Fluoruracil; Fluracedyl; Flurodex; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Pharmachemie Brand of Fluorouracil Monosodium Salt; Pharmacia Brand of Fluorouracil; Ribofluor; Riemser Brand of Fluorouracil; Roche Brand of Fluorouracil; biosyn Brand of Fluorouracil; medac Brand of Fluorouracil; ribosepharm Brand of Fluorouracil; 5 FU Lederle; 5 FU medac; 5 Fluorouracil biosyn; 5 HU Hexal; Dakota, Fluorouracile; Fluoro Uracile ICN; Fluorouracil GRY; Haemato fu; 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-
Relationship Network
Drug Context: Research Results